Results summary | View all lists in GO:BiolProc | View all genes in C05AA.profile.ud50 |
The cascade of processes by which a signal interacts with a receptor, causing a change in the level or activity of a second messenger or other downstream target, and ultimately effecting a change in the functioning of the cell. enrichment: 1.54-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
201203_S_AT | RRBP1 | T | P | S | ![]() |
![]() |
ribosome binding protein 1 homolog 180kDa (dog) | ||||||
214786_AT | MAP3K1 | G | X | P | S | ![]() |
![]() |
mitogen-activated protein kinase kinase kinase 1 | |||||
210367_S_AT | PTGES | E | S | ![]() |
![]() |
prostaglandin E synthase | |||||||
215073_S_AT | NR2F2 | D | E | R | S | ![]() |
![]() |
nuclear receptor subfamily 2, group F, member 2 | |||||
203140_AT | BCL6 | G | D | X | R | C | S | ![]() |
![]() |
B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||
205440_S_AT | NPY1R | E | S | ![]() |
![]() |
neuropeptide Y receptor Y1 | |||||||
202861_AT | PER1 | R | S | ![]() |
![]() |
period homolog 1 (Drosophila) | |||||||
204526_S_AT | TBC1D8 | G | S | ![]() |
![]() |
TBC1 domain family, member 8 (with GRAM domain) | |||||||
205945_AT | IL6R | G | D | X | S | ![]() |
![]() |
interleukin 6 receptor | |||||
221819_AT | RAB35 | T | S | ![]() |
![]() |
RAB35, member RAS oncogene family | |||||||
215990_S_AT | BCL6 | G | D | X | R | C | S | ![]() |
![]() |
B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||
209185_S_AT | IRS2 | G | D | E | S | ![]() |
![]() |
insulin receptor substrate 2 | |||||
203373_AT | SOCS2 | G | S | ![]() |
![]() |
suppressor of cytokine signaling 2 | |||||||
209304_X_AT | GADD45B | G | D | X | S | ![]() |
![]() |
growth arrest and DNA-damage-inducible, beta | |||||
207980_S_AT | CITED2 | D | R | S | ![]() |
![]() |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||
203542_S_AT | KLF9 | D | R | S | ![]() |
![]() |
Kruppel-like factor 9 | ||||||
209369_AT | ANXA3 | S | ![]() |
![]() |
annexin A3 | ||||||||
201389_AT | ITGA5 | C | S | ![]() |
![]() |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | |||||||
211082_X_AT | MARK2 | D | P | S | ![]() |
![]() |
MAP/microtubule affinity-regulating kinase 2 | ||||||
36829_AT | PER1 | R | S | ![]() |
![]() |
period homolog 1 (Drosophila) | |||||||
200878_AT | EPAS1 | D | X | R | S | ![]() |
![]() |
endothelial PAS domain protein 1 | |||||
221009_S_AT | ANGPTL4 | G | D | X | E | S | ![]() |
![]() |
angiopoietin-like 4 | ||||
208960_S_AT | KLF6 | D | R | S | ![]() |
![]() |
Kruppel-like factor 6 | ||||||
210059_S_AT | MAPK13 | X | P | S | ![]() |
![]() |
mitogen-activated protein kinase 13 | ||||||
203439_S_AT | STC2 | C | S | ![]() |
![]() |
stanniocalcin 2 | |||||||
37152_AT | PPARD | G | T | D | E | R | C | S | ![]() |
![]() |
peroxisome proliferator-activated receptor delta | ||
208937_S_AT | ID1 | D | R | S | ![]() |
![]() |
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | ||||||
205067_AT | IL1B | G | X | P | C | S | ![]() |
![]() |
interleukin 1, beta | ||||
209120_AT | NR2F2 | D | E | R | S | ![]() |
![]() |
nuclear receptor subfamily 2, group F, member 2 | |||||
209184_S_AT | IRS2 | G | D | E | S | ![]() |
![]() |
insulin receptor substrate 2 | |||||
206411_S_AT | ABL2 | P | C | S | ![]() |
![]() |
v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene) | ||||||
211833_S_AT | BAX | G | T | D | X | P | S | ![]() |
![]() |
BCL2-associated X protein |